86 related articles for article (PubMed ID: 8317906)
1. Cicaprost does not affect tumor inhibitory potential of cytostatic drugs.
Schirner M; Schneider M
Anticancer Res; 1993; 13(3):743-6. PubMed ID: 8317906
[TBL] [Abstract][Full Text] [Related]
2. [Fundamental study of combination chemotherapy with THP, 5-FU and CDDP for human KB carcinoma cell line and its multidrug resistant cell line KB-C1--usefulness of treatment with 5-FU preceding CDDP].
Kishimoto H; Manno Y; Tanaka H; Moridera K; Urade M
Gan To Kagaku Ryoho; 2001 Apr; 28(4):505-9. PubMed ID: 11329785
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of metastasis by cicaprost in rats with established SMT2A mammary carcinoma growth.
Schirner M; Schneider MR
Cancer Detect Prev; 1997; 21(1):44-50. PubMed ID: 9043762
[TBL] [Abstract][Full Text] [Related]
4. Enhanced antitumor efficacy of nedaplatin with 5-fluorouracil against human squamous carcinoma xenografts.
Takeda Y; Kasai H; Uchida N; Yoshida H; Maekawa R; Sugita K; Yoshioka T
Anticancer Res; 1999; 19(5B):4059-64. PubMed ID: 10628354
[TBL] [Abstract][Full Text] [Related]
5. Effects of RSR13 and oxygen on the cytotoxicity of cisplatin and carboplatin to EMT6 mouse mammary tumor cells in vitro and in vivo.
Donnelly ET; Kelley M; Rockwell S
Cancer Chemother Pharmacol; 2004 Jan; 53(1):43-50. PubMed ID: 14574460
[TBL] [Abstract][Full Text] [Related]
6. The antitumor effect of lowered doses of cytostatics combined with new analogs of vitamin D in mice.
Wietrzyk J; Nevozhay D; Filip B; Milczarek M; Kutner A
Anticancer Res; 2007; 27(5A):3387-98. PubMed ID: 17970085
[TBL] [Abstract][Full Text] [Related]
7. Antitumor efficacy of nedaplatin, a novel platinum complex, with cyclophosphamide in murine and human tumor model.
Uchida N; Takeda Y; Kasai H; Maekawa R; Sugita K; Yoshioka T
Anticancer Res; 1998; 18(5A):3375-9. PubMed ID: 9858911
[TBL] [Abstract][Full Text] [Related]
8. Influence of treatment sequence on efficacy of fluorouracil and cisplatin intratumoral drug delivery in vivo.
Yu NY; Patawaran MB; Chen JY; Orenberg EK; Brown DM; Luck EE
Cancer J Sci Am; 1995; 1(3):215-21. PubMed ID: 9166479
[TBL] [Abstract][Full Text] [Related]
9. Combined effect of cisplatin and 5-fluorouracil with irradiation on tumor cells in vitro.
Nagy B; Mucsi I; Molnár J; Thurzo L
Anticancer Res; 2002; 22(1A):135-8. PubMed ID: 12017276
[TBL] [Abstract][Full Text] [Related]
10. Mechanism(s) of antitumor action in protracted infusion of low dose 5-fluorouracil and cisplatin in gastric carcinoma.
Kim R; Tanabe K; Inoue H; Toge T
Int J Oncol; 2002 Mar; 20(3):549-55. PubMed ID: 11836567
[TBL] [Abstract][Full Text] [Related]
11. Interferon beta increases antitumor activity of 5-fluorouracil against human colon carcinoma cells in vitro and in vivo.
Kase S; Kubota T; Watanabe M; Furukawa T; Tanino H; Ishibiki K; Teramoto T; Kitajima M
Anticancer Res; 1993; 13(2):369-73. PubMed ID: 8517649
[TBL] [Abstract][Full Text] [Related]
12. Antimetastatic action of the prostacyclin analogue cicaprost in experimental mammary tumors.
Schneider MR; Schirner M; Lichtner RB; Graf H
Breast Cancer Res Treat; 1996; 38(1):133-41. PubMed ID: 8825130
[TBL] [Abstract][Full Text] [Related]
13. Highly efficacious nontoxic preclinical treatment for advanced metastatic breast cancer using combination oral UFT-cyclophosphamide metronomic chemotherapy.
Munoz R; Man S; Shaked Y; Lee CR; Wong J; Francia G; Kerbel RS
Cancer Res; 2006 Apr; 66(7):3386-91. PubMed ID: 16585158
[TBL] [Abstract][Full Text] [Related]
14. Acute in vivo resistance in high-dose therapy.
Teicher BA; Ara G; Keyes SR; Herbst RS; Frei E
Clin Cancer Res; 1998 Feb; 4(2):483-91. PubMed ID: 9516940
[TBL] [Abstract][Full Text] [Related]
15. [Apoptosis-inducing and anti-tumor effect of cyclophosphamide, cisplatin and adriamycin used separately or combined in murine lymphosarcoma LS].
Nikolin VP; Kaledin VI; Baĭmak TIu; Galiamova MR; Popova NA; Voĭtsitskiĭ VE
Vopr Onkol; 2002; 48(2):211-5. PubMed ID: 12227071
[TBL] [Abstract][Full Text] [Related]
16. The prostacyclin analogue cicaprost inhibits metastasis of tumours of R 3327 MAT Lu prostate carcinoma and SMT 2A mammary carcinoma.
Schirner M; Schneider MR
J Cancer Res Clin Oncol; 1992; 118(7):497-501. PubMed ID: 1624541
[TBL] [Abstract][Full Text] [Related]
17. Toxicity and antitumor activity of the vitamin D analogs PRI-1906 and PRI-1907 in combined treatment with cyclophosphamide in a mouse mammary cancer model.
Wietrzyk J; Nevozhay D; Milczarek M; Filip B; Kutner A
Cancer Chemother Pharmacol; 2008 Oct; 62(5):787-97. PubMed ID: 18188568
[TBL] [Abstract][Full Text] [Related]
18. Antitumour effect of combination treatment with Sabarubicin (MEN 10755) and cis-platin (DDP) in human lung tumour xenograft.
Bigioni M; Benzo A; Irrissuto C; Lopez G; Curatella B; Maggi CA; Manzini S; Crea A; Caroli S; Cubadda F; Binaschi M
Cancer Chemother Pharmacol; 2008 Sep; 62(4):621-9. PubMed ID: 18038274
[TBL] [Abstract][Full Text] [Related]
19. Optimal scheduling of interleukin 12 and chemotherapy in the murine MB-49 bladder carcinoma and B16 melanoma.
Teicher BA; Ara G; Buxton D; Leonard J; Schaub RG
Clin Cancer Res; 1997 Sep; 3(9):1661-7. PubMed ID: 9815857
[TBL] [Abstract][Full Text] [Related]
20. Modulation of 5-fluorouracil host-toxicity and chemotherapeutic efficacy against human colon tumors by 5-(Phenylthio)acyclouridine, a uridine phosphorylase inhibitor.
Al Safarjalani ON; Rais R; Shi J; Schinazi RF; Naguib FN; el Kouni MH
Cancer Chemother Pharmacol; 2006 Nov; 58(5):692-8. PubMed ID: 16528530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
